Recent Funding
Companies
Ambros Therapeutics

Ambros Therapeutics

Ambros Therapeutics is a clinical-stage biotechnology company.

Latest funding

$125M Series A · December 16, 2025

Led by Patient Square Capital · Source: fundraisingfox.com

Funding history ↓

Website: ambrostherapeutics.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Medical, Therapeutics.

Stage: Series A.

Based in: Irvine, United States.

Founded: 2024.

Last round: Dec 16, 2025 · 331 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredSep 2, 2024 (2 years old)

Funding rounds

December 16, 2025
Series A · $125M
PPatient Square Capital (lead), RRA Capital Management (lead), AAbiogen Pharma, AAdage Capital Management, AArkin Bio Ventures, BBalyasny Asset Management, JJanus Henderson Investors, LLifeSci Venture Partners, TTranshuman Capital
Source: fundraisingfox.com
September 2, 2024
Website created

Founders and team

KK
Kunal Kishnani Founder

LinkedIn
GC
Gail Cawkwell CMO
JH
Joseph Hagan President and Chief Executive Officer
MC
Michael Cruse COO

Acquisitions

Acquired company	Price	Announced
WWerewolf Therapeutics	Not disclosed	Aug 21, 2026 · MSN

Investors

Companies like Ambros Therapeutics

VVaderis Therapeutics$152M Series B+ · Aug 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
FFoRx Therapeutics$50M Series A · Dec 2025
OOne04 TherapeuticsSeed · Sep 2026
CCity TherapeuticsSeries B+ · Aug 2026
CComplement TherapeuticsSeries A · Apr 2023

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ambros-therapeutics (get a free API key).